Rauhamaa H - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Prognostic factors and overall survival among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland study.

Lahelma M, Rauhamaa H, Leskelä RL, Isomeri O, Idänpään-Heikkilä J, Käkelä S, Roebuck N, Mascialino B, Hietanen S, Loukovaara M, Auranen A. Lahelma M, et al. Among authors: rauhamaa h. Acta Oncol. 2024 Oct 16;63:763-771. doi: 10.2340/1651-226X.2024.40324. Acta Oncol. 2024. PMID: 39415562 Free PMC article.

Real-life treatment patterns and time to next treatment among patients with ovarian cancer in the pre-PARP inhibitor era: the OCRWE-Finland Study.

Lahelma M, Rauhamaa H, Isomeri O, Idänpään-Heikkilä J, Käkelä S, Roebuck N, Mascialino B, Hietanen S, Loukovaara M, Auranen A. Lahelma M, et al. Among authors: rauhamaa h. Acta Oncol. 2024 Oct 16;63:772-782. doi: 10.2340/1651-226X.2024.40325. Acta Oncol. 2024. PMID: 39415563 Free PMC article.

A severe neurodegenerative disease with Lewy bodies and a mutation in the glucocerebrosidase gene.

Sipilä JOT, Kytövuori L, Rauramaa T, Rauhamaa H, Kaasinen V, Majamaa K. Sipilä JOT, et al. Among authors: rauhamaa h. NPJ Parkinsons Dis. 2023 Apr 5;9(1):53. doi: 10.1038/s41531-023-00501-4. NPJ Parkinsons Dis. 2023. PMID: 37019925 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters